Systematic construction and validation of an immune prognostic model for lung adenocarcinoma

Clicks: 214
ID: 111606
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #20 of 31 articles by views in Journal of cellular and molecular medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Lung adenocarcinoma (LUAD), the most common non-small-cell lung cancer, is characterized by a dense lymphocytic infiltrate, which indicates that the immune system plays an active role in the development and growth of this cancer. However, no investigations to date have proposed robust models for pre …
Reference Key
c2020journalsystematic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Luo C;Lei M;Zhang Y;Zhang Q;Li L;Lian J;Liu S;Wang L;Pi G;Zhang Y;;
Journal Journal of cellular and molecular medicine
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/31779055/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:31779055 pmc6991688 doi:10.1111/jcmm.14719 chenghan luo mengyuan lei yi zhang

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.